Category: Qui Tam

ATTORNEY NEWSLETTER U.S. Securities and Exchange Commission Tips for Whistleblowers What the Securities Regulators Look For The Securities and Exchange Commission (SEC) needs your help in tracking down securities fraud. Whistleblowers bring useful information to the SEC that can lead to investigation and prosecution –  and a possible reward for […]

ATTORNEY NEWSLETTER  Whistleblower Anonymity The IRS encourages whistleblowers to assist in prosecuting tax fraud and rewards whistleblowers when the government recovers money. From initial application up to trial, the whistleblower’s anonymity can usually be preserved. If the case gets to the Tax Court the whistleblower/relator’s name is likely to be […]

ATTORNEY NEWSLETTER Pharmaceutical Company Settles Whistleblower Case for $456 Million False Claims Act Suit Whistleblower/qui tam cases under the federal False Claims Act (FCA) can be huge. The Department of Justice (DOJ) recently announced a $456 million settlement in one FCA whistleblower/qui tam case against a leading pharmaceutical company. The […]

ATTORNEY NEWSLETTER Fraudulent Ambulance Charges Uncovered False Claims Act Suit Whistleblower/qui tam cases brought under the federal False Claims Act (FCA) typically involve direct, illegal claims for reimbursement or fraudulent billing under government programs such as Medicare and Medicaid.  A recent case involved the alleged practice of “up coding,” where […]

ATTORNEY NEWSLETTER   Defense Contractor Settles Whistleblower Case False Claims Act Suit   Recently, a defense contractor and its subsidiaries settled a large, ongoing whistleblower, or qui tam, lawsuit for allegedly defrauding the government. In the action, the whistleblower/relator alleged that the contractor and several of its subsidiaries had conspired […]

ATTORNEY NEWSLETTER  Whistleblower Case Settles For $280 Million False Claims Act   2017 is developing into a banner year for whistleblower cases under the False Claims Act, especially in the healthcare and pharmaceutical industries. A big whistleblower case against one of the country’s largest bio-pharmaceutical companies recently settled for $280 […]

ATTORNEY NEWSLETTER   Large Whistleblower False Claims Case Unsealed $60 Million Medicaid Fraud Alleged   Whistleblowers often help the government recover money under the federal False Claims Act (FCA). Whistleblower applications are sealed initially until it is decided that the case will proceed in the open.  Recently, a whistleblower (also […]

ATTORNEY NEWSLETTER Attorney General Charges Over 400 in Huge Fraud Case Justice Department Cracks Down on Medicare Fraud Attorney General Jeff Sessions announced today that over 400 physicians, nurses, and other healthcare professionals in 20 different States were being charged in a string of healthcare fraud cases. The cases entail […]

ATTORNEY NEWSLETTER Government Protects Whistleblowers from Retaliation Whistleblowers Gets Job Back In a strong statement of encouragement to whistleblowers the government recently ordered the reinstatement of a bank whistleblower who blew the lid on the bank’s unlawful practices. In a complex national case against one of the country’s largest banks, […]

ATTORNEY NEWSLETTER Ninth Circuit Reinstates Whistleblower Case False Claims Act Suit Recently, the Ninth Circuit reinstated all claims of a whistleblower (also called a “relator” in some whistleblower/qui tam cases) brought under the federal False Claims Act (FCA) against Gilead Sciences, Inc., the large pharmaceutical company. The lawsuit alleges non-compliance […]